Psychological and social interventions for schizophrenia

British Medical Journal

Volumn 333, Issue 7561, 2006, Pages 212-213

  Kingdon, David ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; PERPHENAZINE; PSYCHEDELIC AGENT;

BEHAVIOR THERAPY; CLINICAL PRACTICE; CLINICAL TRIAL; COGNITIVE THERAPY; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EDITORIAL; EMPLOYMENT; HEALTH CARE PERSONNEL; HUMAN; META ANALYSIS; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PSYCHOSIS; RISK FACTOR; SCHIZOPHRENIA; SELF ESTEEM; SOCIAL ASPECT; SYMPTOM; SYSTEMATIC REVIEW; METHODOLOGY; NOTE; PSYCHOTHERAPY;

HUMANS; PSYCHOTHERAPY; SCHIZOPHRENIA;

EID: 33747190595     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.333.7561.212     Document Type: Editorial

References (15)

1. Ganguli R, Strassnig M. Are older antipsychotic drugs obsolete? BMJ 2006;332:1346-7.
2. Tiihonen J, Wahlbeck K, Lönnqvist J, Klaukka T, Ioannidis J, Volavka J, et al. Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study. BMJ 2006;333:224-7.
3. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005;353(12):1209-23.
4. Read J, van Os J, Morrison AP, Ross CA. Childhood trauma, psychosis and schizophrenia: a literature review with theoretical and clinical implications. Acta Psychiatr Scand 2005;112:330-50.
5. Myin-Germeys I, Delespaul P, Van OJ. Behavioral sensitization to daily life stress in psychosis. Psychol Med 2005;(5):733-41.
6. Hall W. Is cannabis use psychotogenic? Lancet 2006;367:193-5.
7. Bentall RP. Madness explained: psychosis and human nature. London: Penguin, 2004.
8. Pilling S, Bebbington P, Kuipers E, Garety P, Geddes J, Orbach G, et al. Psychological treatments in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy. Psychological Medicine 2002;32(5):763-82.
9. Turkington D, Kingdon D, Weiden PJ. Cognitive behavior therapy for schizophrenia. Am J Psychiatry 2006;163:365-73.
10. Kingdon D, Kirschen H. Who does not get referred for cognitive behavior therapy for schizophrenia? Experience from an area where availability has not been limited. Psychiatric Services (in press).
11. Turkington D, Kingdon D, Rathod S, Hammond K, Pelton J, Mehta R. Outcomes of an effectiveness trial of cognitive-behavioural intervention by mental health nurses in schizophrenia. Br J Psychiatry 2006;189:36-40.
12. McGlashan TH, Zipursky RB, Perkins D, Addington J, Miller T, Woods SW, et al. Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry 2006;163:790-9.
13. Cook JA, Leff HS, Blyler CR, Gold PB, Goldberg RW, Mueser KT, et al. Results of a multisite randomized trial of supported employment interventions for individuals with severe mental illness. Arch General Psychiatry 2005;62(:505-12.
14. Harrow M, Grossman LS, Jobe TH, Herbener ES. Do patients with schizophrenia ever show periods of recovery? A 15-year multi-follow-up study. Schizophrenia Bulletin 2005;31(3):723-34.
15. Kingdon D, Gibson A, Turkington D, Rathod S, Morrison A. Acceptable terminology and subgroups in schizophrenia: an exploratory study. Soc Psychiatry Psychiatr Epidemiol (in press).